查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1877842

2025年人工智慧（AI）控制灌註生物反應器市場報告

Perfusion Bioreactor With Artificial Intelligence (AI) Control Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

近年來，人工智慧（AI）控制的灌註生物反應器市場規模迅速擴張，預計將從2024年的15.5億美元成長到2025年的18.8億美元，複合年成長率（CAGR）為21.3%。過去幾年的成長可歸因於一次性生物反應器的日益普及、生物製藥研發投入的增加、對高效細胞培養系統需求的成長、對連續生物加工方法的日益重視以及生產過程自動化程度的提高。

預計未來幾年，人工智慧（AI）控制的灌註生物反應器市場將呈指數級成長，到2029年市場規模將達到40.2億美元，複合年成長率（CAGR）為20.9%。預測期內的成長要素包括：數位健康技術的日益普及、對混合生物反應器解決方案的偏好不斷增強、對先進監測系統的需求不斷成長、個性化醫療應用的不斷拓展以及政府對生物製程創新的日益支持。預測期內的主要趨勢包括：人工智慧驅動控制平台的技術進步、連續生物製程方法的創新、自動化監測和控制系統的開發、精準醫療應用的研究與開發以及與數位化製造生態系統的融合。

未來幾年，人工智慧（AI）控制的灌註生物反應器市場預計將受到個人化醫療日益普及的推動。個人化醫療是一種根據個人的基因、分子和臨床特徵調整治療方法的醫療方法，旨在實現更精準有效的治療。基因組學技術的進步使得基於患者基因譜的治療方法成為可能，從而提高了療效和安全性，進而推動了對個人化醫療的需求。人工智慧（AI）控制的灌註生物反應器透過在嚴格控制的條件下精確、連續地生產患者特異性細胞（例如幹細胞和工程組織）來支持個人化醫療。例如，根據美國非營利組織個人化醫療聯盟（Personalized Medicine Coalition）稱，截至2024年2月，美國食品藥物管理局（FDA）在2023年核准了16種用於治療罕見疾病患者的新型個人化療法，高於2022年的6種。這些新核准的療法包括7種癌症藥物和3種其他疾病的治療方法。因此，個人化醫療的日益普及推動了人工智慧（AI）控制灌註生物反應器市場的成長。

人工智慧（AI）控制灌註生物反應器市場的主要企業正致力於開發創新解決方案，例如AI增強型即時生物過程監測，以最佳化細胞培養性能、提高產品產量並降低生物製藥生產的營運成本。 AI增強型即時生物製程監測利用人工智慧演算法持續分析生物反應器數據，並提供即時洞察、預測性調整以及生物製造過程中細胞生長和產品品質的最佳化。例如，2025年2月，總部位於德國的生物技術公司The Cultivated B GmbH推出了AI驅動的多通道生物感測器，以增強對用於細胞培養和發酵過程的生物反應器的即時監測。這些生物感測器提供連續、高解析度的數據分析，使生物製程工程師能夠以亞皮莫耳級的靈敏度檢測葡萄糖、胺基酸和乳酸等分子，從而追蹤細胞生長和代謝過程。人工智慧的整合可提供即時洞察和建議，以最佳化培養基成分，提高測量精度，消除人工取樣以最大限度地降低污染風險，並加速製藥、生技藥品、食品生物技術、廢棄物增值回收和替代蛋白質生產領域的產品開發。

目錄

第1章執行摘要

第2章 市場特徵

第3章 市場趨勢與策略

第4章 市場：宏觀經濟情景，包括利率、通貨膨脹、地緣政治、貿易戰和關稅，以及新冠疫情及其復甦對市場的影響

第5章 全球成長分析與策略分析框架

  • 全球人工智慧（AI）控制灌註生物反應器市場：PESTEL 分析（政治、社會、技術、環境、法律因素、促進因素和限制因素）
  • 終端用戶產業分析
  • 全球人工智慧（AI）控制灌註生物反應器市場：成長率分析
  • 全球人工智慧（AI）控制灌註生物反應器市場表現：規模與成長，2019-2024年
  • 全球人工智慧（AI）控制灌註生物反應器市場預測：規模與成長，2024-2029年，2034年預測
  • 全球人工智慧（AI）控制灌註生物反應器市場：潛在市場規模（TAM）

第6章 市場細分

  • 全球人工智慧（AI）控制灌註生物反應器市場：按產品類型分類，實際結果和預測，2019-2024年、2024-2029年預測、2034年預測
  • 一次性灌註生物反應器
  • 多用途灌註生物反應器
  • 全球人工智慧（AI）控制灌註生物反應器市場：按AI控制類型分類，實際結果和預測，2019-2024年、2024-2029年預測、2034年預測
  • 預測分析
  • 流程最佳化
  • 即時監控
  • 自動回饋控制
  • 其他人工智慧控制類型
  • 全球人工智慧（AI）控制灌註生物反應器市場：按應用領域分類，實際結果和預測，2019-2024年、2024-2029年預測、2034年預測
  • 細胞療法
  • 單株抗體生產
  • 疫苗生產
  • 幹細胞研究
  • 其他用途
  • 全球人工智慧（AI）控制灌註生物反應器市場：依最終用戶分類，實際值和預測值，2019-2024年、2024-2029年預測值、2034年預測值
  • 生物製藥公司
  • 學術研究機構
  • 契約製造組織
  • 其他最終用戶
  • 全球人工智慧（AI）控制灌註生物反應器市場：按一次性灌註生物反應器類型細分，實際值和預測值，2019-2024年、2024-2029年預測值、2034年預測值
  • 一次性袋式生物反應器
  • 模組化單室生物反應器
  • 無菌單腔生物反應器
  • 全球人工智慧（AI）控制灌註生物反應器市場：多用途灌註生物反應器按類型細分，實際數據及預測（2019-2024年、2024-2029年預測、2034年預測）。
  • 不銹鋼生物反應器
  • 玻璃生物反應器
  • 多容器連續培養系統

第7章 區域和國家分析

  • 全球人工智慧（AI）控制灌註生物反應器市場：區域分析、預測與成長，2019-2024年、2024-2029年預測、2034年預測
  • 全球人工智慧（AI）控制灌註生物反應器市場：國家、性能和預測，2019-2024年、2024-2029年預測、2034年預測

第8章 亞太市場

第9章：中國市場

第10章 印度市場

第11章 日本市場

第12章：澳洲市場

第13章 印尼市場

第14章 韓國市場

第15章 西歐市場

第16章英國市場

第17章：德國市場

第18章：法國市場

第19章：義大利市場

第20章：西班牙市場

第21章 東歐市場

第22章：俄羅斯市場

第23章 北美市場

第24章美國市場

第25章：加拿大市場

第26章 南美洲市場

第27章：巴西市場

第28章 中東市場

第29章：非洲市場

第30章：競爭格局與公司概況

  • 人工智慧（AI）控制灌註生物反應器市場：競爭格局
  • 人工智慧（AI）控制灌註生物反應器市場：公司概況
    • Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Merck KGaA Overview, Products and Services, Strategy and Financial Analysis
    • Lonza Group AG. Overview, Products and Services, Strategy and Financial Analysis
    • Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis
    • Sartorius Aktiengesellschaft Overview, Products and Services, Strategy and Financial Analysis

第31章：其他領先和創新企業

  • Getinge AB.
  • WuXi Biologics Inc.
  • Eppendorf Aktiengesellschaft
  • ABEC Inc.
  • Catalyx.ai
  • PBS Biotech Inc.
  • Cytovance Biologics
  • Culture Biosciences Inc.
  • Esco Lifesciences Group Ltd.
  • Cell Culture Company GmbH
  • Synthecon Inc.
  • OmniBRx Biotechnologies Inc.
  • ProlifeCell Inc.
  • Sciperio Ltd.
  • The Cultivated B Ltd.

第32章 全球市場競爭基準化分析與儀錶板

第33章 重大併購

第34章 近期市場趨勢

第35章：高潛力市場國家、細分市場與策略

  • 2029年人工智慧（AI）控制灌註生物反應器市場：提供新機會的國家
  • 2029年人工智慧（AI）控制灌註生物反應器市場：提供新機會的細分市場
  • 2029年人工智慧（AI）控制灌註生物反應器市場：成長策略
    • 基於市場趨勢的策略
    • 競爭對手策略

第36章附錄

簡介目錄
Product Code: r39317

A perfusion bioreactor with artificial intelligence control is a bioreactor system designed for continuous cell culture that delivers fresh media and removes waste. Artificial intelligence monitors critical parameters and automatically adjusts conditions to optimize productivity, consistency, and efficiency in the manufacturing of biologics or cell-based products.

The main product types of perfusion bioreactors with artificial intelligence control include single-use perfusion bioreactors and multi-use perfusion bioreactors. Single-use perfusion bioreactors are disposable systems used for continuous cell culture that enhance scalability and minimize contamination risks in biomanufacturing. Artificial intelligence control features include predictive analytics, process optimization, real-time monitoring, automated feedback control, and others. These bioreactors are used in applications such as cell therapy, monoclonal antibody production, vaccine manufacturing, stem cell research, and others, and serve end users including biopharmaceutical companies, academic and research institutes, contract manufacturing organizations, and others.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the pharmaceutical companies contend with tariffs on APIs, glass vials, and lab equipment inputs with few alternative sources. Generic drug makers, operating on razor-thin margins, are especially vulnerable, with some reducing production of low-profit medicines. Biotech firms face delays in clinical trials due to tariff-related shortages of specialized reagents. In response, the industry is expanding API production in India and Europe, increasing inventory stockpiles, and pushing for trade exemptions for essential medicines.

The perfusion bioreactor with artificial intelligence (AI) control market research report is one of a series of new reports from The Business Research Company that provides perfusion bioreactor with artificial intelligence (AI) control market statistics, including perfusion bioreactor with artificial intelligence (AI) control industry global market size, regional shares, competitors with a perfusion bioreactor with artificial intelligence (AI) control market share, detailed perfusion bioreactor with artificial intelligence (AI) control market segments, market trends and opportunities, and any further data you may need to thrive in the perfusion bioreactor with artificial intelligence (AI) control industry. This perfusion bioreactor with artificial intelligence (AI) control market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The perfusion bioreactor with artificial intelligence (AI) control market size has grown exponentially in recent years. It will grow from $1.55 billion in 2024 to $1.88 billion in 2025 at a compound annual growth rate (CAGR) of 21.3%. The growth during the historic period can be attributed to the rising adoption of single use bioreactors, the increasing investment in biopharmaceutical research and development, the growing demand for efficient cell culture systems, the expanding focus on continuous bioprocessing approaches, and the increasing level of automation in manufacturing processes.

The perfusion bioreactor with artificial intelligence (AI) control market size is expected to see exponential growth in the next few years. It will grow to $4.02 billion in 2029 at a compound annual growth rate (CAGR) of 20.9%. The growth during the forecast period can be attributed to the rising adoption of digital health technologies, the growing preference for hybrid bioreactor solutions, the increasing demand for advanced monitoring systems, the expanding applications in personalized medicine, and the growing government support for bioprocessing innovation. Major trends during the forecast period include technological advancements in artificial intelligence driven control platforms, innovations in continuous bioprocessing methods, developments in automated monitoring and control systems, research and development in precision medicine applications, and the integration with digital manufacturing ecosystems.

The increasing adoption of personalized medicine is expected to drive the growth of the perfusion bioreactor with artificial intelligence control market in the coming years. Personalized medicine is a medical approach that tailors treatment to an individual's genetic, molecular, and clinical characteristics for more accurate and effective care. The demand for personalized medicine is growing due to advances in genomics, which enable therapies customized to a patient's genetic profile for improved efficacy and safety. Perfusion bioreactors with artificial intelligence control support personalized medicine by enabling precise, continuous production of patient-specific cells, such as stem cells or engineered tissues, under tightly regulated conditions. For example, in February 2024, according to the Personalized Medicine Coalition, a United States-based non-profit organization, the FDA approved 16 new personalized treatments for rare disease patients in 2023, an increase from six approvals in 2022. These newly approved therapies included seven cancer drugs and three treatments for other diseases and conditions. Therefore, the growing adoption of personalized medicine is fueling the expansion of the perfusion bioreactor with artificial intelligence control market.

Leading companies in the perfusion bioreactor with artificial intelligence control market are focusing on developing innovative solutions such as artificial intelligence enhanced real-time bioprocess monitoring to optimize cell culture performance, improve product yield, and lower operational costs in biopharmaceutical manufacturing. Artificial intelligence enhanced real-time bioprocess monitoring involves the use of artificial intelligence algorithms to continuously analyze bioreactor data, providing real-time insights, predictive adjustments, and optimization of cell growth and product quality during biomanufacturing. For instance, in February 2025, The Cultivated B GmbH, a Germany-based biotechnology company, introduced artificial intelligence driven multi-channel biosensors to enhance real-time monitoring of bioreactors used in cell culture and fermentation processes. These biosensors provide continuous, high-resolution data analytics, enabling bioprocess engineers to track growth and metabolism with high sensitivity, detecting molecules at sub-picomolar levels such as glucose, amino acids, and lactic acid. The integration of artificial intelligence provides real-time insights and recommendations to optimize media formulation, enhance measurement accuracy, minimize contamination risk by removing manual sampling, and accelerate product development across pharmaceuticals, biologics, food biotechnology, waste upcycling, and alternative protein production.

In August 2025, Culture Biosciences Inc., a United States-based biotechnology company, partnered with Cytiva Bioscience Holding Ltd. to advance digital bioprocessing solutions. The partnership aims to accelerate and reduce risks in upstream bioprocess development by offering scalable, cloud-connected, and digitally integrated bioreactor systems that enable faster and more reliable therapeutic production from laboratory to commercial scale. Cytiva Bioscience Holding Ltd. is a United States-based biotechnology company that provides perfusion bioreactors with artificial intelligence control.

Major players in the perfusion bioreactor with artificial intelligence (ai) control market are Thermo Fisher Scientific Inc., Merck KGaA, Lonza Group AG., Danaher Corporation, Sartorius Aktiengesellschaft, Getinge AB., WuXi Biologics Inc., Eppendorf Aktiengesellschaft, ABEC Inc., Catalyx.ai, PBS Biotech Inc., Cytovance Biologics, Culture Biosciences Inc., Esco Lifesciences Group Ltd., Cell Culture Company GmbH, Synthecon Inc., OmniBRx Biotechnologies Inc., ProlifeCell Inc., Sciperio Ltd., and The Cultivated B Ltd.

North America was the largest region in the perfusion bioreactor with artificial intelligence (AI) control market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in perfusion bioreactor with artificial intelligence (AI) control report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the perfusion bioreactor with artificial intelligence (AI) control market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The perfusion bioreactor with artificial intelligence (AI) control market consists of revenues earned by entities by providing services such as cell culture management, nutrient and waste regulation, AI-driven process control, performance optimization, and automated data analytics. The market value includes the value of related goods sold by the service provider or included within the service offering. The perfusion bioreactor with artificial intelligence (AI) control market includes sales of automated perfusion bioreactor systems, hybrid perfusion bioreactors, and AI-integrated bench-scale perfusion bioreactors. Values in this market are 'factory gate' values; that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Perfusion Bioreactor With Artificial Intelligence (AI) Control Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on perfusion bioreactor with artificial intelligence (ai) control market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for perfusion bioreactor with artificial intelligence (ai) control ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The perfusion bioreactor with artificial intelligence (ai) control market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Product Type: Single Use Perfusion Bioreactors; Multi-Use Perfusion Bioreactors
  • 2) By Artificial Intelligence (AI) Control Type: Predictive Analytics; Process Optimization; Real-Time Monitoring; Automated Feedback Control; Other Artificial Intelligence (AI) Control Types
  • 3) By Application: Cell Therapy; Monoclonal Antibody Production; Vaccine Manufacturing; Stem Cell Research; Other Applications
  • 4) By End-User: Biopharmaceutical Companies; Academic And Research Institutes; Contract Manufacturing Organizations; Other End-Users
  • Subsegments:
  • 1) By Single-Use Perfusion Bioreactors: Disposable Bag Bioreactors; Modular Single-Chamber Bioreactors; Pre-Sterilized Single-Vessel Bioreactors
  • 2) By Multi-Use Perfusion Bioreactors: Stainless Steel Bioreactors; Glass Bioreactors; Multi-Vessel Continuous Culture Systems
  • Companies Mentioned: Thermo Fisher Scientific Inc.; Merck KGaA; Lonza Group AG.; Danaher Corporation; Sartorius Aktiengesellschaft; Getinge AB.; WuXi Biologics Inc.; Eppendorf Aktiengesellschaft; ABEC Inc.; Catalyx.ai; PBS Biotech Inc.; Cytovance Biologics; Culture Biosciences Inc.; Esco Lifesciences Group Ltd.; Cell Culture Company GmbH; Synthecon Inc.; OmniBRx Biotechnologies Inc.; ProlifeCell Inc.; Sciperio Ltd.; The Cultivated B Ltd.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Perfusion Bioreactor With Artificial Intelligence (AI) Control Market Characteristics

3. Perfusion Bioreactor With Artificial Intelligence (AI) Control Market Trends And Strategies

4. Perfusion Bioreactor With Artificial Intelligence (AI) Control Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

  • 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Perfusion Bioreactor With Artificial Intelligence (AI) Control Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Perfusion Bioreactor With Artificial Intelligence (AI) Control PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Perfusion Bioreactor With Artificial Intelligence (AI) Control Market Growth Rate Analysis
  • 5.4. Global Perfusion Bioreactor With Artificial Intelligence (AI) Control Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Perfusion Bioreactor With Artificial Intelligence (AI) Control Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Perfusion Bioreactor With Artificial Intelligence (AI) Control Total Addressable Market (TAM)

6. Perfusion Bioreactor With Artificial Intelligence (AI) Control Market Segmentation

  • 6.1. Global Perfusion Bioreactor With Artificial Intelligence (AI) Control Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Single-Use Perfusion Bioreactors
  • Multi-Use Perfusion Bioreactors
  • 6.2. Global Perfusion Bioreactor With Artificial Intelligence (AI) Control Market, Segmentation By Artificial Intelligence (AI) Control Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Predictive Analytics
  • Process Optimization
  • Real-Time Monitoring
  • Automated Feedback Control
  • Other Artificial Intelligence (AI) Control Types
  • 6.3. Global Perfusion Bioreactor With Artificial Intelligence (AI) Control Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Cell Therapy
  • Monoclonal Antibody Production
  • Vaccine Manufacturing
  • Stem Cell Research
  • Other Applications
  • 6.4. Global Perfusion Bioreactor With Artificial Intelligence (AI) Control Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Biopharmaceutical Companies
  • Academic And Research Institutes
  • Contract Manufacturing Organizations
  • Other End-Users
  • 6.5. Global Perfusion Bioreactor With Artificial Intelligence (AI) Control Market, Sub-Segmentation Of Single-Use Perfusion Bioreactors, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Disposable Bag Bioreactors
  • Modular Single-Chamber Bioreactors
  • Pre-Sterilized Single-Vessel Bioreactors
  • 6.6. Global Perfusion Bioreactor With Artificial Intelligence (AI) Control Market, Sub-Segmentation Of Multi-Use Perfusion Bioreactors, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Stainless Steel Bioreactors
  • Glass Bioreactors
  • Multi-Vessel Continuous Culture Systems

7. Perfusion Bioreactor With Artificial Intelligence (AI) Control Market Regional And Country Analysis

  • 7.1. Global Perfusion Bioreactor With Artificial Intelligence (AI) Control Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Perfusion Bioreactor With Artificial Intelligence (AI) Control Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Perfusion Bioreactor With Artificial Intelligence (AI) Control Market

  • 8.1. Asia-Pacific Perfusion Bioreactor With Artificial Intelligence (AI) Control Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Perfusion Bioreactor With Artificial Intelligence (AI) Control Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Perfusion Bioreactor With Artificial Intelligence (AI) Control Market, Segmentation By Artificial Intelligence (AI) Control Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Perfusion Bioreactor With Artificial Intelligence (AI) Control Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Perfusion Bioreactor With Artificial Intelligence (AI) Control Market

  • 9.1. China Perfusion Bioreactor With Artificial Intelligence (AI) Control Market Overview
  • 9.2. China Perfusion Bioreactor With Artificial Intelligence (AI) Control Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Perfusion Bioreactor With Artificial Intelligence (AI) Control Market, Segmentation By Artificial Intelligence (AI) Control Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Perfusion Bioreactor With Artificial Intelligence (AI) Control Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Perfusion Bioreactor With Artificial Intelligence (AI) Control Market

  • 10.1. India Perfusion Bioreactor With Artificial Intelligence (AI) Control Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Perfusion Bioreactor With Artificial Intelligence (AI) Control Market, Segmentation By Artificial Intelligence (AI) Control Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Perfusion Bioreactor With Artificial Intelligence (AI) Control Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Perfusion Bioreactor With Artificial Intelligence (AI) Control Market

  • 11.1. Japan Perfusion Bioreactor With Artificial Intelligence (AI) Control Market Overview
  • 11.2. Japan Perfusion Bioreactor With Artificial Intelligence (AI) Control Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Perfusion Bioreactor With Artificial Intelligence (AI) Control Market, Segmentation By Artificial Intelligence (AI) Control Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Perfusion Bioreactor With Artificial Intelligence (AI) Control Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Perfusion Bioreactor With Artificial Intelligence (AI) Control Market

  • 12.1. Australia Perfusion Bioreactor With Artificial Intelligence (AI) Control Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Perfusion Bioreactor With Artificial Intelligence (AI) Control Market, Segmentation By Artificial Intelligence (AI) Control Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Perfusion Bioreactor With Artificial Intelligence (AI) Control Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Perfusion Bioreactor With Artificial Intelligence (AI) Control Market

  • 13.1. Indonesia Perfusion Bioreactor With Artificial Intelligence (AI) Control Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Perfusion Bioreactor With Artificial Intelligence (AI) Control Market, Segmentation By Artificial Intelligence (AI) Control Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Perfusion Bioreactor With Artificial Intelligence (AI) Control Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Perfusion Bioreactor With Artificial Intelligence (AI) Control Market

  • 14.1. South Korea Perfusion Bioreactor With Artificial Intelligence (AI) Control Market Overview
  • 14.2. South Korea Perfusion Bioreactor With Artificial Intelligence (AI) Control Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Perfusion Bioreactor With Artificial Intelligence (AI) Control Market, Segmentation By Artificial Intelligence (AI) Control Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Perfusion Bioreactor With Artificial Intelligence (AI) Control Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Perfusion Bioreactor With Artificial Intelligence (AI) Control Market

  • 15.1. Western Europe Perfusion Bioreactor With Artificial Intelligence (AI) Control Market Overview
  • 15.2. Western Europe Perfusion Bioreactor With Artificial Intelligence (AI) Control Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Perfusion Bioreactor With Artificial Intelligence (AI) Control Market, Segmentation By Artificial Intelligence (AI) Control Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Perfusion Bioreactor With Artificial Intelligence (AI) Control Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Perfusion Bioreactor With Artificial Intelligence (AI) Control Market

  • 16.1. UK Perfusion Bioreactor With Artificial Intelligence (AI) Control Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Perfusion Bioreactor With Artificial Intelligence (AI) Control Market, Segmentation By Artificial Intelligence (AI) Control Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Perfusion Bioreactor With Artificial Intelligence (AI) Control Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Perfusion Bioreactor With Artificial Intelligence (AI) Control Market

  • 17.1. Germany Perfusion Bioreactor With Artificial Intelligence (AI) Control Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Perfusion Bioreactor With Artificial Intelligence (AI) Control Market, Segmentation By Artificial Intelligence (AI) Control Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Perfusion Bioreactor With Artificial Intelligence (AI) Control Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Perfusion Bioreactor With Artificial Intelligence (AI) Control Market

  • 18.1. France Perfusion Bioreactor With Artificial Intelligence (AI) Control Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Perfusion Bioreactor With Artificial Intelligence (AI) Control Market, Segmentation By Artificial Intelligence (AI) Control Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Perfusion Bioreactor With Artificial Intelligence (AI) Control Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Perfusion Bioreactor With Artificial Intelligence (AI) Control Market

  • 19.1. Italy Perfusion Bioreactor With Artificial Intelligence (AI) Control Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Perfusion Bioreactor With Artificial Intelligence (AI) Control Market, Segmentation By Artificial Intelligence (AI) Control Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Perfusion Bioreactor With Artificial Intelligence (AI) Control Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Perfusion Bioreactor With Artificial Intelligence (AI) Control Market

  • 20.1. Spain Perfusion Bioreactor With Artificial Intelligence (AI) Control Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Perfusion Bioreactor With Artificial Intelligence (AI) Control Market, Segmentation By Artificial Intelligence (AI) Control Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Perfusion Bioreactor With Artificial Intelligence (AI) Control Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Perfusion Bioreactor With Artificial Intelligence (AI) Control Market

  • 21.1. Eastern Europe Perfusion Bioreactor With Artificial Intelligence (AI) Control Market Overview
  • 21.2. Eastern Europe Perfusion Bioreactor With Artificial Intelligence (AI) Control Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Perfusion Bioreactor With Artificial Intelligence (AI) Control Market, Segmentation By Artificial Intelligence (AI) Control Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Perfusion Bioreactor With Artificial Intelligence (AI) Control Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Perfusion Bioreactor With Artificial Intelligence (AI) Control Market

  • 22.1. Russia Perfusion Bioreactor With Artificial Intelligence (AI) Control Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Perfusion Bioreactor With Artificial Intelligence (AI) Control Market, Segmentation By Artificial Intelligence (AI) Control Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Perfusion Bioreactor With Artificial Intelligence (AI) Control Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Perfusion Bioreactor With Artificial Intelligence (AI) Control Market

  • 23.1. North America Perfusion Bioreactor With Artificial Intelligence (AI) Control Market Overview
  • 23.2. North America Perfusion Bioreactor With Artificial Intelligence (AI) Control Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Perfusion Bioreactor With Artificial Intelligence (AI) Control Market, Segmentation By Artificial Intelligence (AI) Control Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Perfusion Bioreactor With Artificial Intelligence (AI) Control Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Perfusion Bioreactor With Artificial Intelligence (AI) Control Market

  • 24.1. USA Perfusion Bioreactor With Artificial Intelligence (AI) Control Market Overview
  • 24.2. USA Perfusion Bioreactor With Artificial Intelligence (AI) Control Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Perfusion Bioreactor With Artificial Intelligence (AI) Control Market, Segmentation By Artificial Intelligence (AI) Control Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Perfusion Bioreactor With Artificial Intelligence (AI) Control Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Perfusion Bioreactor With Artificial Intelligence (AI) Control Market

  • 25.1. Canada Perfusion Bioreactor With Artificial Intelligence (AI) Control Market Overview
  • 25.2. Canada Perfusion Bioreactor With Artificial Intelligence (AI) Control Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Perfusion Bioreactor With Artificial Intelligence (AI) Control Market, Segmentation By Artificial Intelligence (AI) Control Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Perfusion Bioreactor With Artificial Intelligence (AI) Control Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Perfusion Bioreactor With Artificial Intelligence (AI) Control Market

  • 26.1. South America Perfusion Bioreactor With Artificial Intelligence (AI) Control Market Overview
  • 26.2. South America Perfusion Bioreactor With Artificial Intelligence (AI) Control Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Perfusion Bioreactor With Artificial Intelligence (AI) Control Market, Segmentation By Artificial Intelligence (AI) Control Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Perfusion Bioreactor With Artificial Intelligence (AI) Control Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Perfusion Bioreactor With Artificial Intelligence (AI) Control Market

  • 27.1. Brazil Perfusion Bioreactor With Artificial Intelligence (AI) Control Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Perfusion Bioreactor With Artificial Intelligence (AI) Control Market, Segmentation By Artificial Intelligence (AI) Control Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Perfusion Bioreactor With Artificial Intelligence (AI) Control Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Perfusion Bioreactor With Artificial Intelligence (AI) Control Market

  • 28.1. Middle East Perfusion Bioreactor With Artificial Intelligence (AI) Control Market Overview
  • 28.2. Middle East Perfusion Bioreactor With Artificial Intelligence (AI) Control Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Perfusion Bioreactor With Artificial Intelligence (AI) Control Market, Segmentation By Artificial Intelligence (AI) Control Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Perfusion Bioreactor With Artificial Intelligence (AI) Control Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Perfusion Bioreactor With Artificial Intelligence (AI) Control Market

  • 29.1. Africa Perfusion Bioreactor With Artificial Intelligence (AI) Control Market Overview
  • 29.2. Africa Perfusion Bioreactor With Artificial Intelligence (AI) Control Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Perfusion Bioreactor With Artificial Intelligence (AI) Control Market, Segmentation By Artificial Intelligence (AI) Control Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Perfusion Bioreactor With Artificial Intelligence (AI) Control Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Perfusion Bioreactor With Artificial Intelligence (AI) Control Market Competitive Landscape And Company Profiles

  • 30.1. Perfusion Bioreactor With Artificial Intelligence (AI) Control Market Competitive Landscape
  • 30.2. Perfusion Bioreactor With Artificial Intelligence (AI) Control Market Company Profiles
    • 30.2.1. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Merck KGaA Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Lonza Group AG. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Sartorius Aktiengesellschaft Overview, Products and Services, Strategy and Financial Analysis

31. Perfusion Bioreactor With Artificial Intelligence (AI) Control Market Other Major And Innovative Companies

  • 31.1. Getinge AB.
  • 31.2. WuXi Biologics Inc.
  • 31.3. Eppendorf Aktiengesellschaft
  • 31.4. ABEC Inc.
  • 31.5. Catalyx.ai
  • 31.6. PBS Biotech Inc.
  • 31.7. Cytovance Biologics
  • 31.8. Culture Biosciences Inc.
  • 31.9. Esco Lifesciences Group Ltd.
  • 31.10. Cell Culture Company GmbH
  • 31.11. Synthecon Inc.
  • 31.12. OmniBRx Biotechnologies Inc.
  • 31.13. ProlifeCell Inc.
  • 31.14. Sciperio Ltd.
  • 31.15. The Cultivated B Ltd.

32. Global Perfusion Bioreactor With Artificial Intelligence (AI) Control Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Perfusion Bioreactor With Artificial Intelligence (AI) Control Market

34. Recent Developments In The Perfusion Bioreactor With Artificial Intelligence (AI) Control Market

35. Perfusion Bioreactor With Artificial Intelligence (AI) Control Market High Potential Countries, Segments and Strategies

  • 35.1 Perfusion Bioreactor With Artificial Intelligence (AI) Control Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Perfusion Bioreactor With Artificial Intelligence (AI) Control Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Perfusion Bioreactor With Artificial Intelligence (AI) Control Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer